LCI 1461 (Dipyridamole 25 mg)

Pill imprint LCI 1461 has been identified as Dipyridamole 25 mg.

Dipyridamole is used in the treatment of radionuclide myocardial perfusion study; prosthetic heart valves - thrombosis prophylaxis and belongs to the drug classes cardiac stressing agents, platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Dipyridamole 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for LCI 1461

Dipyridamole 25 mg LCI 1461
Dipyridamole
Imprint:
LCI
1461
Strength:
25 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Cardiac stressing agents
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lannett Company, Inc.
National Drug Code (NDC):
00527-1461
Inactive Ingredients:
microcrystalline cellulose
povidone k29/32
crospovidone
lactose monohydrate
silicon dioxide colloidal
magnesium stearate
FD&C Red No. 40
FD&C Yellow No. 6
soya lecithin
polyethylene glycol
polyvinyl alcohol
magnesium silicate
titanium dioxide
aluminum oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
10135-0536 Marlex Pharmaceuticals Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)